Blue Mountain Home Health Care Inc | |
1851 W End Avenue Suite A, Pottsville, Pennsylvania 17901 | |
(570) 622-4444 | |
Name | Blue Mountain Home Health Care Inc |
---|---|
Location | 1851 W End Avenue Suite A, Pottsville, Pennsylvania |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Home Health Aide |
Medicare ID | 398203 |
Ownership Type | Proprietary |
Service Area Zip Codes | 17222, 17851, 17872, 17901, 17921, 17922, 17954, 17957, 17959, 17960, 17961, 17963, 17965, 17968, 17970, 17972, 17976, 17978, 17980, 17983, 18250, 18252, 19607 |
NPI Number | 1669749339 |
Organization Name | BLUE MOUNTAIN HOME HEALTH CARE, INC |
Address | 1851 W End Ave, Suite A, Pottsville, PA 17901 |
Phone Number | 570-622-4444 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
For children with Batten disease and their families, the cruelty of the disease, which robs children of their sight, their cognitive faculties and finally their lives, is made worse by the hunt for a doctor experienced at recognizing and treating patients.
Long-term sick leave is a burden for individuals and society at large, yet very little is known about the underlying reasons for it. Researchers at the Norwegian Institute of Public Health, in collaboration with Australian and British institutes, have identified anxiety as a more important risk factor than previously thought.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
› Verified 3 days ago
Quality Rating: |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
For children with Batten disease and their families, the cruelty of the disease, which robs children of their sight, their cognitive faculties and finally their lives, is made worse by the hunt for a doctor experienced at recognizing and treating patients.
Long-term sick leave is a burden for individuals and society at large, yet very little is known about the underlying reasons for it. Researchers at the Norwegian Institute of Public Health, in collaboration with Australian and British institutes, have identified anxiety as a more important risk factor than previously thought.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 95.9 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 94.4 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 70.5 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 63.8 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 92.3 | 96.4 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
For children with Batten disease and their families, the cruelty of the disease, which robs children of their sight, their cognitive faculties and finally their lives, is made worse by the hunt for a doctor experienced at recognizing and treating patients.
Long-term sick leave is a burden for individuals and society at large, yet very little is known about the underlying reasons for it. Researchers at the Norwegian Institute of Public Health, in collaboration with Australian and British institutes, have identified anxiety as a more important risk factor than previously thought.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 53.6 | 79.6 |
How often patients got better at getting in and out of bed | 66.6 | 81.1 |
How often patients got better at bathing | 58.5 | 82.3 |
How often patients’ breathing improved | 43.2 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 54.5 | 75 |
How often home health patients had to be admitted to the hospital | 13.7 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | - | 13 |
How often physician-recommended actions to address medication issues were completely timely | 91.9 | 94 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
For children with Batten disease and their families, the cruelty of the disease, which robs children of their sight, their cognitive faculties and finally their lives, is made worse by the hunt for a doctor experienced at recognizing and treating patients.
Long-term sick leave is a burden for individuals and society at large, yet very little is known about the underlying reasons for it. Researchers at the Norwegian Institute of Public Health, in collaboration with Australian and British institutes, have identified anxiety as a more important risk factor than previously thought.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
› Verified 3 days ago
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
For children with Batten disease and their families, the cruelty of the disease, which robs children of their sight, their cognitive faculties and finally their lives, is made worse by the hunt for a doctor experienced at recognizing and treating patients.
Long-term sick leave is a burden for individuals and society at large, yet very little is known about the underlying reasons for it. Researchers at the Norwegian Institute of Public Health, in collaboration with Australian and British institutes, have identified anxiety as a more important risk factor than previously thought.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
› Verified 3 days ago
Lehigh Valley Health Network Location: 420 South Jackson St, Pottsville, Pennsylvania 17901 Ratings: Phone: (570) 621-5050 | |
Kings Home Healthcare, Inc Location: 51 Ann Street, Pottsville, Pennsylvania 17901 Ratings: Phone: (570) 875-1711 | |
Blue Mountain Home Health Care Inc Location: 1851 W End Avenue Suite A, Pottsville, Pennsylvania 17901 Ratings: Phone: (570) 622-4444 | |
Advantage Home Health And Hospice Location: 1502 Route 61 Highway, Pottsville, Pennsylvania 17901 Ratings: Phone: (570) 668-6300 |